@article{c1eec62fdaae4a0da91a1fd619178dd8,
title = "Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells",
author = "L. Eadie and Hughes, \{T. P.\} and White, \{D. L.\}",
note = "Funding Information: This research was supported by the Leukaemia Foundation of Australia. Special thanks to Novartis Pharmaceuticals for the provision of imatinib and nilotinib.",
year = "2010",
doi = "10.1038/leu.2010.7",
language = "English",
volume = "24",
pages = "855--857",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "4",
}